SharpLink to Host Third Quarter 2025 Financial Results Conference Call and Webcast on November 13, 2025 at 8:30 A.M. E.T.

SharpLink to Host Third Quarter 2025 Financial Results Conference Call and Webcast on November 13, 2025 at 8:30 A.M. E.T. GlobeNewswire November 06, 2025 MINNEAPOLIS, MN, Nov. 06, 2025 (GLOBE NEWSWIRE) — SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”), one of the world's largest corporate holders of Ether (“ETH”) and prominent industry advocate […]

Chemomab Announces Multiple Presentations at AASLD The Liver Meeting(R) 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis

Chemomab Announces Multiple Presentations at AASLD The Liver Meeting(R) 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis GlobeNewswire November 06, 2025 — Phase 2 SPRING Trial Open Label Extension Showed Favorable Safety and Consistent Improvements in Key Biomarkers in PSC Patients Treated with Nebokitug for Up to 48 Weeks–

BioCryst Presents New Data at ACAAI Highlighting Burden of HAE on Pediatric Patients and Caregivers and Sustained Reduction of Attacks in Children Treated with One Year of ORLADEYO(R) (berotralstat)

(NASDAQ:BCRX), – Findings highlight negative psychosocial impact of HAE attacks and resulting ED/hospital visits on pediatric patients and their caregivers – – ORLADEYO oral granules demonstrated early and sustained reduction in HAE attacks over one year of treatment in second interim analysis of APeX-P – – ORLADEYO oral granules are currently under review with U.S.

LiveOne (Nasdaq: LVO) to Announce Its Second Quarter Fiscal Year 2026 Financial Results and Host Investor Webcast on November 12, 2025, at 10:00 am Eastern Time (7:00 am Pacific Time)

LiveOne (Nasdaq: LVO) to Announce Its Second Quarter Fiscal Year 2026 Financial Results and Host Investor Webcast on November 12, 2025, at 10:00 am Eastern Time (7:00 am Pacific Time) GlobeNewswire November 06, 2025 LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), leading music, entertainment, and social platform delivering premium livestreams, digital

Upexi to Host First Quarter 2026 Earnings Call on November 11th at 5:30 p.m. ET

(NASDAQ:UPXI), TAMPA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) — Upexi, Inc. (NASDAQ: UPXI) (the “Company” or “Upexi”), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that it plans to host a conference call and report its financial results for the first quarter 2026 ended September 30, 2025, on Tuesday, November

LM Funding Announces Third Quarter 2025 Earnings Call for November 14, 2025

LM Funding Announces Third Quarter 2025 Earnings Call for November 14, 2025 GlobeNewswire November 06, 2025 TAMPA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company, today announced that it has scheduled its third quarter 2025 earnings conference call and

Workhorse Group Reminds Shareholders to Vote Today FOR All Proposals

Workhorse Group Reminds Shareholders to Vote Today FOR All Proposals GlobeNewswire November 06, 2025 CINCINNATI, Nov. 06, 2025 (GLOBE NEWSWIRE) — Workhorse Group, Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today mailed a letter to shareholders reminding them to vote today FOR

Terra Innovatum Global to Report Third Quarter 2025 Financial Results and Provide Business Update on November 17, 2025

(NasdaqGM:NKLR), NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — Terra Innovatum Global N.V. (“Terra Innovatum” or the “Company“) (NASDAQ: NKLR), a developer of micro-modular nuclear reactors, announced it will release its third quarter fiscal year 2025 financial results before the opening of financial markets on Monday, November 17, 2025. The Company will conduct a conference

Locafy Reports Strong Commercial Momentum Going into CY 2026

Locafy Reports Strong Commercial Momentum Going into CY 2026 GlobeNewswire November 06, 2025 A$156k in monthly subscription sales added in two months Localizer delivering both strong SEO and AEO results for local businesses Advanced AEO analytics solution to be deployed by end of CY 2025 PERTH, Australia, Nov. 06, 2025 (GLOBE NEWSWIRE) — Locafy Limited

UroGen Reports Third Quarter 2025 Financial Results as ZUSDURI(TM) Launch Gains Momentum

(NasdaqGM:URGN), Reported three-month complete response rate of 77.8% from the Phase 3 UTOPIA trial of UGN-103, consistent with ENVISION results; FDA agreed to regulatory plan to submit an NDA based on data from the UTOPIA trial ZUSDURI received unique J-Code (J9282) in October 2025, effective January 1, 2026 ZUSDURI achieved net product revenue of $1.8

Scroll to Top